Registry of Congenital Dyserythropoietic Anemia

Key facts

Sponsor

Lille Catholic University

Principal Investigator

Benjamin Carpentier, MD, MD

GHICL

Intervention

Collection of data and genetic analysis(other)

Enrollment

200 enrolled

Eligibility

All sexes

Timeline

2017 – 2022

Study locations (1)

• Hôpital Saint-Vincent de Paul, Lille, Hauts-de-France, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Congenital dyserythropoietic anemia

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1NCT07471516
  Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia
  Institute of Hematology & Blood Diseases Hospital, China
• RECRUITINGNCT07206095
  Integrative Diagnosis for SCD and Other RADs
  Hospital Universitari Vall d'Hebron Research Institute
• RECRUITINGNCT02964494
  The Congenital Dyserythropoietic Anemia Registry (CDAR)
  Children's Hospital Medical Center, Cincinnati

See all trials for Congenital dyserythropoietic anemia →